Important: The POPLINE website will retire on September 1, 2019. Click here to read about the transition.

Programmatic and research considerations for hormonal contraception for women at risk of HIV and women living with HIV.

Author: 
World Health Organization [WHO]. Department of Reproductive Health and Research
Source: 
Geneva, Switzerland, WHO, Department of Reproductive Health and Research, 2012 May. [4] p. (Policy Implications; WHO/RHR/12.09)
Abstract: 

Between 31 January and 2 February 2012, the World Health Organization (WHO) convened a meeting of experts to discuss recent research on use of hormonal contraception by women at high risk of HIV and those currently living with HIV and its implications. The purpose of the meeting was to review all available published evidence on the relationship between the use of hormonal contraceptives and the risk of HIV acquisition, HIV disease progression, and HIV transmission to uninfected partners, and to determine whether any change in the WHO recommendations on hormonal contraceptive use by women at high risk of, or living with, HIV-infection was needed. During the discussion on the balance of risks and benefits of hormonal contraceptive use among women at high risk of, or living with, HIV infection, multiple programmatic and research issues emerged, including priority knowledge gaps. This brief serves to highlight actions that programmes providing sexual and reproductive health and HIV-prevention services should undertake, in order to complement the Consultation’s recommendations. Directions for future research to address current gaps are noted. (Excerpts)

Language: 
Year: 
Region / Country: 
Document Number: 
333971
Add to my documents. Add to My Documents